In Rezaeian's study [21], the hypoxia-responsive TRAF6 overexpression promotes breast cancer progression and metastasis to lung and spinal bone, and targeting of TRAF6 reduces breast cancer metastasis, opening up opportunities for therapeutic intervention. The gene discussed is TRAF6; the disease is breast cancer.